Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis

Filip M. Segers(Maastricht University Medical Centre), Sander S. Rensen(Maastricht University Medical Centre), Charlotte de Jonge(Maastricht University Medical Centre), Nicole D. Bouvy(Maastricht University), Ann Driessen(University of Antwerp), Bas Boonen(Maastricht University Medical Centre), Wim A. Buurman(Unknown), Jan Greve(Maastricht University), Ronit Shiri‐Sverdlov(Maastricht University), Froukje J. Verdam(Maastricht University Medical Centre)
PLoS ONE
October 9, 2014
10.1371/journal.pone.0110053
Cited by 51

Related Papers

The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|Cells|2020|538
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
|Thorax|1996|524
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†
|Hepatology|2008|467
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
|Nature Communications|2013|298
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
|Journal of Hepatology|2005|241